Please assess the completion status of the following clinical trial:

Trial Title: SHERLOCK 3CG™ Diamond Tip Confirmation System

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_ONLY
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Male or female, ≥ 21 years of age with altered cardiac rhythm (no recognizable P-wave on standard ECG) with diagnosis of specific arrhythmia type or identification of pacemaker driven rhythms as defined below:~  1. Atrial fibrillation with history of diagnosis per 12-lead ECG in medical record or diagnosed via bedside telemetry by study team RN at assessment, or~ 2. All other arrhythmias (including but not limited to atrial flutter, PAC, PVC, PJC, tachycardia, AV Block, BB Block) with history of diagnosis per 12-lead ECG in medical record or diagnosed via bedside telemetry by cardiac unit RN at assessment, or retrospectively by site cardiologist, or~ 3. Pacemaker driven rhythm with temporary or permanent pacemaker device in place;~* Subject requires PICC placement as part of standard of care;~* Subject or Legally Authorized Representative (LAR) has signed an Informed Consent Form (ICF).~Exclusion Criteria:~* Subject has a contraindication to PICC placement as listed in the Instructions for Use (IFU) to include:~  1. The presence of bacteremia or septicemia (known or suspected),~ 2. The patient's body size is insufficient to accommodate the size of the implanted device,~ 3. The patient is known or is suspected to be allergic to materials contained in the device,~ 4. Past irradiation of prospective insertion site,~ 5. Previous episodes of venous thrombosis or vascular surgical procedures at the prospective placement site,~ 6. Local tissue factors will prevent proper device stabilization and/or access;~* Subjects who previously had a PICC in place and require a PICC exchange;~* Subject has presence of active resting tremor (i.e. Parkinson's, Multiple Sclerosis, etc.) deemed by Investigator to have potential impact on procedure accuracy;~* Subjects who are pregnant or think they may be pregnant.

- Gender: ALL
- Minimum Age: 21 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- PICC Placement with Study Device (Type: None): PICC Placement with SHERLOCK 3CG™ Diamond TCS with MODUS II software

Based on this trial design, predict the completion outcome and termination type (if applicable).